Belite Bio’s Post

Participate in this webinar to gain valuable insights from subject matter experts (SMEs) as they share their expertise in crafting and assessing rare disease trials across various respiratory conditions. Explore effective strategies for surmounting challenges that commonly emerge throughout the clinical development, testing and regulatory clearance phases of rare disease treatment. https://buff.ly/3sOZE6g #RareDisease #ClinicalDevelopment #ClinicalResearch #RespiratoryDisease

This Rare Disease Month, take direct action in the battle against myasthenia gravis. Urge your MG patients to join the MGFA Global Patient Registry. Your recommendation can make a real difference. Patient data is crucial for advancing MG research and paving the way toward better treatments and a potential cure. Encourage your patients to sign up at mgregistry.org and contribute to meaningful medical progress. #RareDiseaseMonth #MGFA #MGstrong

Join Woo U and Dr. Selina Mcgee on April 24th! This course will cover an overview of the clinical overview of dry eye disease and the impact of preservatives on the ocular surface, the downsides of preservatives, and an update on novel formulations for dry eye disease treatment. Register now! Here is the link: https://lnkd.in/gNaKPTcy #DryEye #EyeHealth #EyeCare #Optometry #DryEyeDisease #EyeHealthMatters #WooUWebinar

We are so proud YPrime’s eCOA has become a critical part for clinical trials in rare diseases like Pediatric Angelman Syndrome. YPrime’s ability to significantly enhance data quality, patient engagement, and trial efficiency by providing improved accuracy, reducing errors, and enabling remote data collection reinforces our promise of “Solving for Certainty” YPrime’s innovative eCOA solution lessens the burden on #patients and #caregivers while ensuring high-quality data collection—crucial in small patient populations. YPrime’s one of a kind comprehensive / flexibile technology is purpose built for the customization requirements specific to rare disease needs. Additionally, YPrime’s global reach facilitates consistent data collection across diverse sites, essential for all rare disease trials that often span multiple countries. These combined benefits make YPrime’s eCOA an invaluable tool in optimizing rare disease clinical trials, aimed at accelerating the development of new treatments for conditions like Pediatric Angelman Syndrome.

Clinical trials look at new ways to prevent, detect, or treat disease. How can we work to improve access and reduce barriers to clinical trial participation and keep patients informed of opportunities? September is #GynecologicCancerAwarenessMonth #GCAM

Need help navigating your Lyme disease diagnosis? Find a Lyme literate medical professional, learn about testing options and more! Visit our resources page below. https://lnkd.in/gSJAVhym . . . #lymedisease #bartonella #babesia #ticks #tickborneillness #lymetreatmentfoundation #lymetreatmentforall

We are Passionate About Rare Disease! At Opus Regulatory our consultants have deep and varied expertise in the Rare Disease space. Below are some of the conditions consultants from all regulatory areas have worked on. We work with our clients every day to make a meaningful difference in patient's lives. #raredisease #regulatoryconsulting #impact #regulatorylabeling #AdPromo #CMC #regulatorystrategy

The battle against syphilis just got a powerful boost with the recent release of significant recommendations by the United States Centers for Disease Control and Prevention (CDC), as highlighted in the Morbidity and Mortality Weekly Report (MMWR). These recommendations provide comprehensive guidance on the tests and protocols necessary for the accurate diagnosis of syphilis in the United States. With the alarming rise in syphilis cases globally, especially in developed nations like ours, these recommendations couldn't come at a more critical time. Click the link below to access the full article: https://bit.ly/4caSuvE Follow us for Daily Stories in the Medical Space #SyphilisDiagnosis #InfectiousDiseases #PublicHealth #CDC #MMWR #HealthcareUpdates #DiagnosticRecommendations #TreponemaPallidum #SyphilisAwareness #MedicalScience #SexualHealth

Need help with your rare disease studies? See how YPrime supported this rare disease study by delivering our advanced, configurable #eCOA platform—transitioning from a previous vendor during the open-label extension (OLE) to drive clinical trial success. Read the case study here: https://hubs.ly/Q02L5XLn0 #RareDiseaseStudies, #YPrime, #eCOAPlatform

Live from #PCRLV: "The roadmap will be a very useful tool to bridge the gap between the patient and the clinician," - Wil Woan, Heart Valve Voice. Read our new roadmap to the successful implementation of shared decision-making in #heartvalve disease now - https://bit.ly/3ucBcwB